In this study, we assess the circulating levels of coagulation factors (factors XI, XII, XIII, and prothrombin) and antithrombin in individuals who completed two doses of either ChAdOx1-S or BNT162b2 COVID-19 vaccine and had no previous history of COVID-19. The gene discussed is F2; the disease is COVID-19.